Betaseron unit-dose program from HMI to address compliance, dosing issues.
Executive Summary
HMI PHARMACEUTICAL UNIT-DOSE BETASERON PROGRAM enhances ease of dose escalation and dose titration for the multiple sclerosis therapy, the company maintains in promotional materials. As part of its Betaseron "disease management" program for MS patients, HMI is retailing custom unit-dose packages of Betaseron (Chiron/Berlex' recombinant human beta interferon-1b).